Literature DB >> 27096028

MicroRNAs as diagnostic and prognostic biomarkers in colorectal cancer.

Rui Yi1, Yao Li1, Fei-Liang Wang1, Gang Miao1, Ruo-Mei Qi1, Yan-Yang Zhao1.   

Abstract

MicroRNAs (miRNAs) are key regulators involved in various tumors. They regulate cell cycle, apoptosis and cancer stemness, metastasis and chemoresistance by controlling their target gene expressions. Here, we mainly discuss the potential uses of miRNAs in colorectal cancer (CRC) diagnosis. We also shed light on the important corresponding miRNA targets and on the major regulators of miRNAs. Furthermore, we discuss miRNA activity in assessing the prognosis and recurrence of CRC as well as in modulating responsiveness to chemotherapy. Based on the various pro-oncogenic/anti-oncogenic roles of miRNAs, the advantages of a therapeutic strategy based on the delivery of miRNA mimics are also mentioned. Together, miRNA seems to be an excellent tool for effectively monitoring and targeting CRC.

Entities:  

Keywords:  Biomarkers; Colorectal cancer; Diagnosis; MicroRNA; Prognosis

Year:  2016        PMID： 27096028      PMCID： PMC4824711          DOI： 10.4251/wjgo.v8.i4.330

Source DB:  PubMed          Journal:  World J Gastrointest Oncol


  104 in total

1.  A plasma microRNA panel for detection of colorectal adenomas: a step toward more precise screening for colorectal cancer.

Authors:  Ziad Kanaan; Henry Roberts; M Robert Eichenberger; Adrian Billeter; Gairy Ocheretner; Jianmin Pan; Shesh N Rai; Jeffery Jorden; Anna Williford; Susan Galandiuk
Journal:  Ann Surg       Date:  2013-09       Impact factor: 12.969

Review 2.  RECK--a newly discovered inhibitor of metastasis with prognostic significance in multiple forms of cancer.

Authors:  Jonathan C M Clark; David M Thomas; Peter F M Choong; Crispin R Dass
Journal:  Cancer Metastasis Rev       Date:  2007-12       Impact factor: 9.264

3.  MicroRNA expression profiles associated with prognosis and therapeutic outcome in colon adenocarcinoma.

Authors:  Aaron J Schetter; Suet Yi Leung; Jane J Sohn; Krista A Zanetti; Elise D Bowman; Nozomu Yanaihara; Siu Tsan Yuen; Tsun Leung Chan; Dora L W Kwong; Gordon K H Au; Chang-Gong Liu; George A Calin; Carlo M Croce; Curtis C Harris
Journal:  JAMA       Date:  2008-01-30       Impact factor: 56.272

4.  Epigenetic silencing of microRNA-34b/c and B-cell translocation gene 4 is associated with CpG island methylation in colorectal cancer.

Authors:  Minoru Toyota; Hiromu Suzuki; Yasushi Sasaki; Reo Maruyama; Kohzoh Imai; Yasuhisa Shinomura; Takashi Tokino
Journal:  Cancer Res       Date:  2008-06-01       Impact factor: 12.701

5.  Correlation between expression of miR-155 in colon cancer and serum carcinoembryonic antigen level and its contribution to recurrence and metastasis forecast.

Authors:  Cao Hongliang; Huang Shaojun; Liu Aihua; Jiang Hua
Journal:  Saudi Med J       Date:  2014-06       Impact factor: 1.484

6.  MicroRNA-34a mediates the autocrine signaling of PAR2-activating proteinase and its role in colonic cancer cell proliferation.

Authors:  Yiming Ma; Wuyun Bao-Han; Xue Lv; Yuntao Su; Xinhua Zhao; Yongmei Yin; Xingmao Zhang; Zhixiang Zhou; Wallace K MacNaughton; Hongying Wang
Journal:  PLoS One       Date:  2013-08-26       Impact factor: 3.240

7.  Computational analysis of mRNA expression profiles identifies microRNA-29a/c as predictor of colorectal cancer early recurrence.

Authors:  Tai-Yue Kuo; Edward Hsi; I-Ping Yang; Pei-Chien Tsai; Jaw-Yuan Wang; Suh-Hang Hank Juo
Journal:  PLoS One       Date:  2012-02-13       Impact factor: 3.240

8.  MicroRNA- 130b suppresses migration and invasion of colorectal cancer cells through downregulation of integrin β1 [corrected].

Authors:  Yanyang Zhao; Gang Miao; Yao Li; Tomoya Isaji; Jianguo Gu; Jian Li; Ruomei Qi
Journal:  PLoS One       Date:  2014-02-03       Impact factor: 3.240

9.  Prognostic role of microRNA-21 in colorectal cancer: a meta-analysis.

Authors:  Xiaochun Xia; Baixia Yang; Xiaogang Zhai; Xiangyang Liu; Kang Shen; Zhijun Wu; Jing Cai
Journal:  PLoS One       Date:  2013-11-12       Impact factor: 3.240

10.  miR-29b suppresses tumor growth and metastasis in colorectal cancer via downregulating Tiam1 expression and inhibiting epithelial-mesenchymal transition.

Authors:  B Wang; W Li; H Liu; L Yang; Q Liao; S Cui; H Wang; L Zhao
Journal:  Cell Death Dis       Date:  2014-07-17       Impact factor: 8.469
View more
  11 in total

1.  A tumor-suppressive microRNA, miRNA-485-5p, inhibits glioma cell proliferation and invasion by down-regulating TPD52L2.

Authors:  Jin Yu; Shi-Wen Wu; Wei-Ping Wu
Journal:  Am J Transl Res       Date:  2017-07-15       Impact factor: 4.060

Review 2.  Colorectal Cancer: From the Genetic Model to Posttranscriptional Regulation by Noncoding RNAs.

Authors:  María Antonia Lizarbe; Jorge Calle-Espinosa; Eva Fernández-Lizarbe; Sara Fernández-Lizarbe; Miguel Ángel Robles; Nieves Olmo; Javier Turnay
Journal:  Biomed Res Int       Date:  2017-05-10       Impact factor: 3.411

3.  Current Evidence on miRNAs as Potential Theranostic Markers for Detecting Chemoresistance in Colorectal Cancer: A Systematic Review and Meta-Analysis of Preclinical and Clinical Studies.

Authors:  Madhav Madurantakam Royam; Chellan Kumarasamy; Siddhartha Baxi; Ajay Gupta; Nachimuthu Ramesh; Gothandam Kodiveri Muthukaliannan; Rama Jayaraj
Journal:  Mol Diagn Ther       Date:  2019-02       Impact factor: 4.074

4.  Identification of the Minimum Combination of Serum microRNAs to Predict the Recurrence of Colorectal Cancer Cases.

Authors:  Yukihiro Yoshikawa; Mitsuko Fukunaga; Junichi Takahashi; Dai Shimizu; Takaaki Masuda; Tsunekazu Mizushima; Kazutaka Yamada; Masaki Mori; Hidetoshi Eguchi; Yuichiro Doki; Takahiro Ochiya; Koshi Mimori
Journal:  Ann Surg Oncol       Date:  2022-09-29       Impact factor: 4.339

5.  A meta-analysis on the prognosis of exosomal miRNAs in all solid tumor patients.

Authors:  Jiupeng Zhou; Hui Guo; Yuanli Yang; Yongfeng Zhang; Heng Liu
Journal:  Medicine (Baltimore)       Date:  2019-04       Impact factor: 1.817

6.  [ARTICLE WITHDRAWN] MicroRNA-539 Inhibits the Epithelial-Mesenchymal Transition of Esophageal Cancer Cells by Twist-Related Protein 1-Mediated Modulation of Melanoma-Associated Antigen A4.

Authors:  Zhili Cao; Xiang Zheng; Lei Cao; Naixin Liang
Journal:  Oncol Res       Date:  2017-06-12       Impact factor: 5.574

7.  miRNA-335 and miRNA-182 affect the occurrence of tongue squamous cell carcinoma by targeting survivin.

Authors:  Deming Ou; Ying Wu; Jun Liu; Xiaomei Lao; Sien Zhang; Guiqing Liao
Journal:  Oncol Lett       Date:  2016-08-03       Impact factor: 2.967

Review 8.  The Role of Bioactive Dietary Components in Modulating miRNA Expression in Colorectal Cancer.

Authors:  Laura I Gavrilas; Corina Ionescu; Oana Tudoran; Cosmin Lisencu; Ovidiu Balacescu; Doina Miere
Journal:  Nutrients       Date:  2016-09-26       Impact factor: 5.717

9.  Systematic literature review and clinical validation of circulating microRNAs as diagnostic biomarkers for colorectal cancer.

Authors:  Cheng Pan; Xuebing Yan; Hao Li; Linsheng Huang; Mingming Yin; Yongzhi Yang; Renyuan Gao; Leiming Hong; Yanlei Ma; Chenzhang Shi; Huanlong Qin; Peng Zhang
Journal:  Oncotarget       Date:  2017-07-18

10.  MicroRNA-744 Inhibits Cellular Proliferation and Invasion of Colorectal Cancer by Directly Targeting Oncogene Notch1.

Authors:  Jian Shen; Minzhe Li
Journal:  Oncol Res       Date:  2018-02-22       Impact factor: 5.574
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.